guanidine has been researched along with zanamivir in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Arai, M; Honda, T; Masuda, T; Yamashita, M; Yoshida, S | 1 |
Cheng, YS; Fang, JM; Lee, PS; Liu, KC; Wang, SY; Wong, CH | 1 |
Chang, TC; Das, A; Fang, MY; Hsu, KC; Hsu, TA; Hung, HC; Lin, CC; Lin, CH; Mong, KK; von Itzstein, M; Yang, JM | 1 |
Govorkova, EA; Ivachtchenko, AV; Ivanenkov, YA; Ivashchenko, AA; Jones, JC; Karapetian, RN; Pascua, PNQ; Penaflor, MK; Shkil, DO | 1 |
4 other study(ies) available for guanidine and zanamivir
Article | Year |
---|---|
Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives.
Topics: Animals; Antiviral Agents; Enzyme Inhibitors; Glutamic Acid; Glyceryl Ethers; Guanidine; Guanidines; Influenza A virus; Inhibitory Concentration 50; Mice; N-Acetylneuraminic Acid; Neuraminidase; Orthomyxoviridae Infections; Pyrans; Sialic Acids; Structure-Activity Relationship; Viral Plaque Assay; Zanamivir | 2002 |
Intramolecular ion-pair prodrugs of zanamivir and guanidino-oseltamivir.
Topics: Administration, Oral; Antiviral Agents; Carbon Dioxide; Cell Line; Drug Evaluation, Preclinical; Enzyme Inhibitors; Esters; Guanidine; Humans; Hydrophobic and Hydrophilic Interactions; Influenza A virus; Influenza, Human; Ions; Molecular Structure; Naphthols; Neuraminidase; Oseltamivir; Prodrugs; Zanamivir | 2011 |
Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanidine; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Microbial Sensitivity Tests; Molecular Structure; Neuraminidase; Structure-Activity Relationship; Zanamivir | 2013 |
Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza A and B viruses.
Topics: Antiviral Agents; Drug Resistance, Viral; Enzyme Inhibitors; Guanidine; Guanidines; Herpesvirus 1, Cercopithecine; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza A Virus, H7N9 Subtype; Influenza, Human; Neuraminidase; Oseltamivir; Zanamivir | 2023 |